Ludwig Christian Hinske Selected Research

S-(beta-p-methoxypropiophenone)thiamine (MB 2)

2/2022

Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ludwig Christian Hinske Research Topics

Disease

3	Sepsis (Septicemia) 03/2022 - 08/2021
3	Pain (Aches) 01/2018 - 01/2015
2	Venous Thromboembolism 03/2022 - 08/2021
2	Neoplasms (Cancer) 01/2018 - 01/2017
1	Thrombocytopenia (Thrombopenia) 03/2022
1	Thrombosis (Thrombus) 03/2022
1	Vasoplegia 02/2022
1	Hypotension (Low Blood Pressure) 02/2022
1	Stroke (Strokes) 01/2020
1	Inflammation (Inflammations) 01/2018
1	Low Back Pain (Lumbago) 02/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Neuralgia (Stump Neuralgia) 01/2015

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
2	Pharmaceutical PreparationsIBA 03/2022 - 08/2021
1	Heparin (Liquaemin)FDA LinkGeneric 03/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 02/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2022
1	Vasopressins (Vasopressin)IBA 02/2022
1	S-(beta-p-methoxypropiophenone)thiamine (MB 2)IBA 02/2022
1	AnticoagulantsIBA 08/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2021
1	Dabigatran FDA Link 01/2020
1	RivaroxabanIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	CytokinesIBA 01/2015
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2015
1	InterleukinsIBA 01/2015
1	InterferonsIBA 01/2015
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2015

Therapy/Procedure

2	Therapeutics 02/2022 - 02/2017
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2018
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2022
1	Anesthesia 01/2018